We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00007657
Recruitment Status : Completed
First Posted : January 4, 2001
Last Update Posted : June 15, 2009
Sponsor:
Collaborators:
Medical Research Council of Canada
Merck Sharp & Dohme Corp.
Pfizer
GE Healthcare
Bristol-Myers Squibb
Astellas Pharma Inc
AstraZeneca
Sanofi
Datascope Corp.
First Horizon
Kos
Key Pharmaceuticals
Integrated Therapeutics Group
Hoest-Marion-Roussel
Information provided by:
VA Office of Research and Development

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : June 2006
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):